{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T12:09:19Z","timestamp":1769083759420,"version":"3.49.0"},"posted":{"date-parts":[[2022,3,16]]},"group-title":"Nephrology","reference-count":56,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2022,3,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The prevalence of chronic kidney disease (CKD) is increasing worldwide; black patients have an increased risk of developing CKD and end stage kidney disease (ESKD) at significantly higher rates than other races.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A cross sectional study was carried out on black patients with CKD attending the kidney outpatient clinic at Charlotte Maxeke Johannesburg Academic Hospital (CMJAH) in South Africa, between September 2019 to March 2020. Demographic and clinical data were extracted from the ongoing kidney outpatient clinic records and interviews, and were filled in a questionnaire. Patients provided blood and urine for laboratory investigations as standard of care, data were descriptively and inferentially analysed using STATA version 17. Multivariable logistic regression analysis was used to identify demographic and clinical data associated with advanced CKD.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>\n                    A total of 312 black patients with CKD were enrolled during the study period; 58% patients had advanced CKD, of whom 31.5 % had grossly increased proteinuria, 96.7 % had hypertension, 38.7 % had diabetes mellitus and 38.1 % had both hypertension and diabetes mellitus. For patients with advanced CKD, the median age was 61 (IQR 51-69) years, eGFR 33 (30 -39) mL\/min\/1.73 m\n                    <jats:sup>2<\/jats:sup>\n                    , serum bicarbonate 22 (IQR 20 \u2013 24), hemoglobin 12.9 (IQR 11.5 \u2013 14.0) g\/dl, serum transferrin 2.44 (IQR 2.23 \u2013 2.73) g\/L, serum uric acid 0.43 (IQR 0.37 \u2013 0.53) and serum potassium 4.4 (IQR 3.9 \u2013 4.8) mmol\/L. The prevalence of metabolic acidosis was 62.4 %, anemia 46.4 %, gout 30.9 %, low transferrin levels 16.6 % and hyperkalemia 8.8 % among those with advanced CKD, while the prevalence of metabolic acidosis and anemia was 46.6 % and 25.9 % respectively in those with early CKD. Variables with higher odds for advanced CKD after multivariable logistic regression analysis were hypertension (OR 3.3, 95 % CI 1.2 - 9.2, P = 0.020), diabetes mellitus (OR 1.8, 95 % CI 1.1 - 3.3, P = 0.024), severe proteinuria (OR 3.5, 95 % CI 1.9 - 6.5, P = 0.001), angina (OR 2.5, 95 % CI 1.2 - 5.1, P = 0.008), anaemia (OR 2.9, 95% CI 1.7 - 4.9, P= 0.001), hyperuricemia (OR 2.4, 95 % CI 1.4 - 4.1, P = 0.001), and metabolic acidosis (OR 2.0, 95% CI 1.2 - 3.1, P= 0.005). Other associations with advanced CKD were widow\/widower (OR 3.2, 95 % CI 1.4 - 7.4, P = 0.006), low transferrin (OR 2.4, 95% CI 1.1 - 5.1, P= 0.028), hyperkalemia (OR 5.4, 95% CI 1.2 - 24.1, P= 0.029), allopurinol (OR 2.4, 95 % CI 1.4 - 4.3, P = 0.005) and doxazosin (OR 1.9, 95% CI 1.2 - 3.1, P = 0.006).\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Hypertension and diabetes mellitus were strongly associated with advanced CKD, suggesting a need for primary and secondary population-based prevention measures. Metabolic acidosis, anaemia with low transferrin levels, hyperuricemia and hyperkalemia were highly prevalent in our patients, including those with early CKD, and they were strongly associated with advanced CKD, calling for the proactive role of clinicians and dietitians in supporting the needs of CKD patients in meeting their daily dietary requirements towards preventing and slowing the progression of CKD.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2022.03.16.22272477","type":"posted-content","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T23:20:14Z","timestamp":1647472814000},"source":"Crossref","is-referenced-by-count":1,"title":["Demographic and clinical profile of black patients with chronic kidney disease attending Charlotte Maxeke Johannesburg Academic Hospital (CMJAH) in Johannesburg, South Africa"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5349-7717","authenticated-orcid":false,"given":"Alfred J.","family":"Meremo","sequence":"first","affiliation":[]},{"given":"Graham","family":"Paget","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Duarte","sequence":"additional","affiliation":[]},{"given":"Caroline","family":"Dickens","sequence":"additional","affiliation":[]},{"given":"Therese","family":"Dix-Peek","sequence":"additional","affiliation":[]},{"given":"Deogratius","family":"Bintabara","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7058-9725","authenticated-orcid":false,"given":"Saraladevi","family":"Naicker","sequence":"additional","affiliation":[]}],"member":"54368","reference":[{"key":"2022031807500528000_2022.03.16.22272477v1.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015069"},{"key":"2022031807500528000_2022.03.16.22272477v1.2","doi-asserted-by":"crossref","unstructured":"Hill NR , Fatoba ST , Oke JL , Hirst JA , O\u2019Callaghan CA , Lasserson DS , et al. Global Prevalence of Chronic Kidney Disease \u2013 A Systematic Review and Meta-Analysis. PLoS ONE. 2016;11(7).","DOI":"10.1371\/journal.pone.0158765"},{"issue":"3","key":"2022031807500528000_2022.03.16.22272477v1.3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrneph.2017.181","article-title":"Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease","volume":"14","year":"2018","journal-title":"Nature reviews Nephrology"},{"issue":"12","key":"2022031807500528000_2022.03.16.22272477v1.4","doi-asserted-by":"crossref","first-page":"e1632","DOI":"10.1016\/S2214-109X(19)30443-7","article-title":"Kidney damage and associated risk factors in rural and urban sub-Saharan Africa (AWI-Gen): a cross-sectional population study","volume":"7","year":"2019","journal-title":"The Lancet Global Health"},{"issue":"2","key":"2022031807500528000_2022.03.16.22272477v1.5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.kisu.2017.07.006","article-title":"Closing the gap between evidence and practice in chronic kidney disease","volume":"7","year":"2017","journal-title":"Kidney International Supplements"},{"issue":"3","key":"2022031807500528000_2022.03.16.22272477v1.6","first-page":"363","article-title":"Prevalence of chronic kidney disease and association with cardiovascular risk factors among teachers in Cape Town, South Africa","volume":"10","year":"2017","journal-title":"Clinical Kidney Journal"},{"issue":"3","key":"2022031807500528000_2022.03.16.22272477v1.7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.nefroe.2017.05.010","article-title":"Prevalence and risk of progression of chronic kidney disease in diabetics and hypertensive patients followed by primary care physicians","volume":"37","year":"2017","journal-title":"Nefrolog\u00eda (English Edition)"},{"issue":"2","key":"2022031807500528000_2022.03.16.22272477v1.8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/ckj\/sfx083","article-title":"Patterns of progression of chronic kidney disease at later stages","volume":"11","year":"2018","journal-title":"Clinical kidney journal"},{"issue":"1","key":"2022031807500528000_2022.03.16.22272477v1.9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12882-018-0930-5","article-title":"Burden of chronic kidney disease on the African continent: a systematic review and meta-analysis","volume":"19","year":"2018","journal-title":"BMC Nephrol"},{"issue":"10","key":"2022031807500528000_2022.03.16.22272477v1.10","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1111\/jch.13672","article-title":"Prevalence and predictors of chronic kidney disease among Ghanaian patients with hypertension and diabetes mellitus: A multicenter cross-sectional study","volume":"21","year":"2019","journal-title":"Journal of clinical hypertension (Greenwich, Conn)"},{"key":"2022031807500528000_2022.03.16.22272477v1.11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.nefro.2017.04.006","article-title":"Hyperuricemia is associated with progression of chronic kidney disease in patients with reduced functioning kidney mass","volume":"38","year":"2018","journal-title":"Nefrolog\u00eda (Madrid)"},{"issue":"2","key":"2022031807500528000_2022.03.16.22272477v1.12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000488816","article-title":"Disorders of Lipid Metabolism in Chronic Kidney Disease","volume":"46","year":"2018","journal-title":"Blood Purification"},{"issue":"6","key":"2022031807500528000_2022.03.16.22272477v1.13","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.kint.2018.01.008","article-title":"Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe","volume":"93","year":"2018","journal-title":"Kidney international"},{"issue":"2","key":"2022031807500528000_2022.03.16.22272477v1.14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.xkme.2020.12.006","article-title":"Metabolic Acidosis in CKD: A Review of Recent Findings","volume":"3","year":"2021","journal-title":"Kidney medicine"},{"issue":"1","key":"2022031807500528000_2022.03.16.22272477v1.15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1053\/j.ajkd.2020.08.005","article-title":"Assessing Acid-Base Status in Patients With CKD: Does Measurement of Blood pH Matter?","volume":"77","year":"2021","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"2022031807500528000_2022.03.16.22272477v1.16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12882-020-01852-3","article-title":"Ethnic minority disparities in progression and mortality of pre-dialysis chronic kidney disease: a systematic scoping review","volume":"21","year":"2020","journal-title":"BMC Nephrology"},{"key":"2022031807500528000_2022.03.16.22272477v1.17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/IJNRD.S179802","article-title":"Ethnic prevalence of anemia and predictors of anemia among chronic kidney disease patients at a tertiary hospital in Johannesburg, South Africa","volume":"12","year":"2019","journal-title":"International journal of nephrology and renovascular disease"},{"issue":"4","key":"2022031807500528000_2022.03.16.22272477v1.18","doi-asserted-by":"crossref","first-page":"e0230980","DOI":"10.1371\/journal.pone.0230980","article-title":"Prevalence of anemia in predialysis chronic kidney disease: Is the study center a significant factor?","volume":"15","year":"2020","journal-title":"PloS one"},{"key":"2022031807500528000_2022.03.16.22272477v1.19","unstructured":"Shaikh H , Aeddula NR . Anemia Of Chronic Renal Disease. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2022, StatPearls Publishing LLC.; 2022."},{"key":"2022031807500528000_2022.03.16.22272477v1.20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000484288","article-title":"Treatment of Hyperuricemia in Chronic Kidney Disease","volume":"192","year":"2018","journal-title":"Contributions to nephrology"},{"issue":"4","key":"2022031807500528000_2022.03.16.22272477v1.21","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000464260","article-title":"Elevated Serum Uric Acid Level Predicts Rapid Decline in Kidney Function","volume":"45","year":"2017","journal-title":"American Journal of Nephrology"},{"issue":"6","key":"2022031807500528000_2022.03.16.22272477v1.22","first-page":"0300060520919224","article-title":"A retrospective cross-sectional study of the associated factors of hyperuricemia in patients with chronic kidney disease","volume":"48","year":"2020","journal-title":"Journal of International Medical Research"},{"issue":"5","key":"2022031807500528000_2022.03.16.22272477v1.23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.nefroe.2019.10.001","article-title":"Association of hyperkalemia with clinical outcomes in advanced chronic kidney disease","volume":"39","year":"2019","journal-title":"Nefrolog\u00eda (English Edition)"},{"issue":"Suppl 1","key":"2022031807500528000_2022.03.16.22272477v1.24","doi-asserted-by":"crossref","first-page":"s31","DOI":"10.1590\/1806-9282.66.s1.31","article-title":"Hyperkalemia in chronic kidney disease","volume":"66","year":"2020","journal-title":"Revista da Associacao Medica Brasileira (1992)"},{"key":"2022031807500528000_2022.03.16.22272477v1.25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020145"},{"issue":"7","key":"2022031807500528000_2022.03.16.22272477v1.26","first-page":"e9499","article-title":"Survival of the Fittest: Addressing the Disparities in the Burden of Chronic Kidney Disease","volume":"12","year":"2020","journal-title":"Cureus"},{"key":"2022031807500528000_2022.03.16.22272477v1.27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193384"},{"issue":"9","key":"2022031807500528000_2022.03.16.22272477v1.28","doi-asserted-by":"crossref","first-page":"e2127014","DOI":"10.1001\/jamanetworkopen.2021.27014","article-title":"Trends in Chronic Kidney Disease Care in the US by Race and Ethnicity, 2012-2019","volume":"4","year":"2021","journal-title":"JAMA network open"},{"key":"2022031807500528000_2022.03.16.22272477v1.29","doi-asserted-by":"crossref","unstructured":"Jacobs I , Taljaard-Krugell C , Wicks M , Cubasch H , Joffe M , Laubscher R , et al. Dietary Patterns and Breast Cancer Risk in Black Urban South African Women: The SABC Study. Nutrients. 2021;13(11).","DOI":"10.3390\/nu13114106"},{"key":"2022031807500528000_2022.03.16.22272477v1.30","unstructured":"Research NS . Health Survey for England 2016: adult health trends. Health and Social Care Information Centre London; 2017."},{"key":"2022031807500528000_2022.03.16.22272477v1.31","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.12791019"},{"key":"2022031807500528000_2022.03.16.22272477v1.32","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2018.12.044"},{"issue":"12","key":"2022031807500528000_2022.03.16.22272477v1.33","doi-asserted-by":"crossref","first-page":"e1587","DOI":"10.1016\/S2214-109X(19)30467-X","article-title":"Chronic kidney disease in sub-Saharan Africa","volume":"7","year":"2019","journal-title":"The Lancet Global Health"},{"key":"2022031807500528000_2022.03.16.22272477v1.34","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04330418"},{"issue":"2","key":"2022031807500528000_2022.03.16.22272477v1.35","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1053\/j.ajkd.2020.07.018","article-title":"Kidney, Cardiac, and Safety Outcomes Associated With \u03b1-Blockers in Patients With CKD: A Population-Based Cohort Study","volume":"77","year":"2021","journal-title":"American journal of kidney diseases : the official journal of the National Kidney Foundation"},{"key":"2022031807500528000_2022.03.16.22272477v1.36","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-1064-1"},{"issue":"2","key":"2022031807500528000_2022.03.16.22272477v1.37","doi-asserted-by":"crossref","first-page":"e0246509","DOI":"10.1371\/journal.pone.0246509","article-title":"Prevalence and associated factors of impaired renal function and albuminuria among adult patients admitted to a hospital in Northeast Ethiopia","volume":"16","year":"2021","journal-title":"PloS one"},{"issue":"5","key":"2022031807500528000_2022.03.16.22272477v1.38","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.ekir.2018.04.008","article-title":"Renal Outcomes of Antidiabetic Treatment Options for Type 2 Diabetes\u2014A Proposed MARE Definition","volume":"3","year":"2018","journal-title":"Kidney International Reports"},{"key":"2022031807500528000_2022.03.16.22272477v1.39","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000920"},{"issue":"10","key":"2022031807500528000_2022.03.16.22272477v1.40","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1007\/s12325-021-01886-5","article-title":"Prevalence of Metabolic Acidosis Among Patients with Chronic Kidney Disease and Hyperkalemia","volume":"38","year":"2021","journal-title":"Advances in therapy"},{"issue":"5","key":"2022031807500528000_2022.03.16.22272477v1.41","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.xkme.2021.04.011","article-title":"Metabolic Acidosis and Cardiovascular Disease in CKD","volume":"3","year":"2021","journal-title":"Kidney medicine"},{"issue":"3","key":"2022031807500528000_2022.03.16.22272477v1.42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000487716","article-title":"Addressing Racial Disparity in the Progression of Chronic Kidney Disease: Prescribe More Fruits and Vegetables?","volume":"47","year":"2018","journal-title":"American Journal of Nephrology"},{"issue":"3","key":"2022031807500528000_2022.03.16.22272477v1.43","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.jrn.2020.08.001","article-title":"Treatment of Chronic Kidney Disease-Related Metabolic Acidosis With Fruits and Vegetables Compared to NaHCO(3) Yields More and Better Overall Health Outcomes and at Comparable Five-Year Cost","volume":"31","year":"2021","journal-title":"Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation"},{"key":"2022031807500528000_2022.03.16.22272477v1.44","doi-asserted-by":"crossref","unstructured":"Naber T , Purohit S. Chronic Kidney Disease: Role of Diet for a Reduction in the Severity of the Disease. Nutrients. 2021;13(9).","DOI":"10.3390\/nu13093277"},{"issue":"9","key":"2022031807500528000_2022.03.16.22272477v1.45","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41581-020-0297-2","article-title":"Plant-based diets to manage the risks and complications of chronic kidney disease","volume":"16","year":"2020","journal-title":"Nature reviews Nephrology"},{"key":"2022031807500528000_2022.03.16.22272477v1.46","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.050686"},{"issue":"1","key":"2022031807500528000_2022.03.16.22272477v1.47","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/s41598-020-80877-y","article-title":"Incidence of cardiovascular events and mortality in Korean patients with chronic kidney disease","volume":"11","year":"2021","journal-title":"Scientific Reports"},{"key":"2022031807500528000_2022.03.16.22272477v1.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.08.1017"},{"key":"2022031807500528000_2022.03.16.22272477v1.49","doi-asserted-by":"crossref","unstructured":"Rosenstock JL , Pommier M , Stoffels G , Patel S , Michelis MF . Prevalence of Proteinuria and Albuminuria in an Obese Population and Associated Risk Factors. Frontiers in Medicine. 2018;5(122).","DOI":"10.3389\/fmed.2018.00122"},{"issue":"11","key":"2022031807500528000_2022.03.16.22272477v1.50","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.mayocp.2019.09.014","article-title":"How Do We Navigate the Complexities Surrounding the Use of Angiotensin-Converting Enzyme Inhibitors\/Angiotensin Receptor Blockers in Chronic Kidney Disease?","volume":"94","year":"2019","journal-title":"Mayo Clinic Proceedings"},{"issue":"19","key":"2022031807500528000_2022.03.16.22272477v1.51","doi-asserted-by":"crossref","first-page":"e009992","DOI":"10.1161\/JAHA.118.009992","article-title":"Use of Antihypertensive Agents and Association With Risk of Adverse Outcomes in Chronic Kidney Disease: Focus on Angiotensin\u2010Converting Enzyme Inhibitors and Angiotensin Receptor Blockers","volume":"7","year":"2018","journal-title":"Journal of the American Heart Association"},{"key":"2022031807500528000_2022.03.16.22272477v1.52","unstructured":"Leon SJ , Whitlock R , Rigatto C , Komenda P , Bohm C , Sucha E , et al. Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study. American Journal of Kidney Diseases."},{"issue":"1","key":"2022031807500528000_2022.03.16.22272477v1.53","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1038\/s41598-019-38991-z","article-title":"Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population","volume":"9","year":"2019","journal-title":"Scientific Reports"},{"issue":"8","key":"2022031807500528000_2022.03.16.22272477v1.54","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40265-020-01290-3","article-title":"ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3\u20135: A Network Meta-Analysis of Randomised Clinical Trials","volume":"80","year":"2020","journal-title":"Drugs"},{"issue":"12","key":"2022031807500528000_2022.03.16.22272477v1.55","doi-asserted-by":"crossref","first-page":"e0188975","DOI":"10.1371\/journal.pone.0188975","article-title":"Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis","volume":"12","year":"2017","journal-title":"PloS one"},{"issue":"5","key":"2022031807500528000_2022.03.16.22272477v1.56","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1053\/j.ajkd.2020.10.006","article-title":"Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study","volume":"77","year":"2021","journal-title":"American journal of kidney diseases : the official journal of the National Kidney Foundation"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2022.03.16.22272477","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:39:18Z","timestamp":1768487958000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2022.03.16.22272477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":56,"URL":"https:\/\/doi.org\/10.1101\/2022.03.16.22272477","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1371\/journal.pone.0266155","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2022,3,16]]},"subtype":"preprint"}}